This publication aims to improve treatment and care for adults with chronic obstructive pulmonary disease (COPD). It provides commissioners with strategies and recommendations for frontline care, ...

According to a recent review, digital technology can be used for COPD self-management, learning correct inhaler technique, and receiving care from health care professionals. The aim of the review was ...

Could mobile technology help patients with chronic obstructive pulmonary disease (COPD) who may not seek care until they experience an exacerbation? A recent study found a wearable device and mobile ...

Chronic obstructive pulmonary disease (COPD) remains a major public health challenge, imposing significant burdens through persistent respiratory symptoms, reduced physical capacity and a ...

Australia: A new study has found that among people with chronic obstructive pulmonary disease (COPD), beta-blocker therapy ...

Wellinks ®, a digital health care company offering the first-ever integrated, virtual Chronic Obstructive Pulmonary Disease (COPD) management solution, today announced results from a study that found ...

Why is it that we have not seen the urgency in COPD management we would expect for a disease of this burden and scale? As a trained pulmonologist, and having dedicated my career to advancing ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Leah J. Witt, MD: ...

In a review, investigators concluded that physicians should use pulmonary function tests in addition to standard spirometry evaluations to better ensure that patients are appropriately being diagnosed ...

A larger role for PCPs in COPD management COPD and overall health status impact each other, so it's only right for primary-care clinicians to be major players in fighting this condition. In the latest ...

Wellinks, the company behind a digital platform and connected devices for chronic obstructive pulmonary disease, raised $25 million in Series C funding. The round was led by Morningside Ventures with ...